Related Experiment Video
Updated: May 9, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
On the origins of the androgen receptor low molecular weight species
Maria Mudryj1, Clifford G Tepper
1Veterans Affairs-Northern California Health Care System, Mather, CA 95655, USA. mmudryj@ucdavis.edu
Abstract:
Prostate cancer (CaP), a commonly diagnosed malignancy, is readily treated by androgen ablation. This treatment temporarily halts the disease, but castration-resistant neoplasms that are refractory to current therapies emerge. While these neoplasms are no longer dependent on physiological levels of androgens, they remain reliant on the expression of the androgen receptor (AR). There are multiple mechanisms by which CaP cells circumvent androgen ablation therapies. These include AR mutations that broaden ligand specificity, AR overexpression, AR activation by growth factors and cytokines, overexpression of AR co-activators, altered steroid metabolism, and a locus-wide histone transcriptional activation of some AR targets. This review focuses on a more recently described mechanism: the expression of low molecular weight AR species that are missing the ligand-binding domain and function independently of ligand to drive proliferation. The etiology, biological activity, unique features, predictive value, and therapeutic implication of these androgen receptor isoforms are discussed in depth.
Insights
Castration-resistant prostate cancer (CaP) progresses due to androgen receptor (AR) activity. This review details novel, ligand-independent AR variants driving CaP proliferation and treatment resistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer (CaP) is a common malignancy effectively treated by androgen ablation.
- However, castration-resistant prostate cancer (CRPC) emerges, becoming refractory to therapies.
- CRPC remains reliant on androgen receptor (AR) expression despite lacking dependence on physiological androgens.
Purpose of the Study:
- To review mechanisms by which prostate cancer cells circumvent androgen ablation therapies.
- To focus on the role of low molecular weight AR species lacking a ligand-binding domain.
- To discuss the etiology, biological activity, and therapeutic implications of these novel AR isoforms.
Main Methods:
- Literature review of studies on prostate cancer and androgen receptor signaling.
- Analysis of mechanisms contributing to castration resistance.
- In-depth discussion of specific AR isoforms and their functional characteristics.
Main Results:
- Multiple mechanisms allow CaP cells to resist androgen ablation, including AR mutations, overexpression, and altered co-activator function.
- A key mechanism involves the expression of low molecular weight AR species that lack the ligand-binding domain.
- These AR variants function independently of androgens to drive tumor proliferation.
Conclusions:
- Novel androgen receptor isoforms lacking a ligand-binding domain represent a significant mechanism of castration resistance in prostate cancer.
- Understanding these AR variants is crucial for developing new therapeutic strategies.
- These isoforms may serve as predictive biomarkers and therapeutic targets for advanced prostate cancer.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
Related Concept Videos
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Intracellular Hormone Receptors
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...